| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10285), 1637-1645, 2021 | 511* | 2021 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 253 | 2022 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 200 | 2021 |
| Australian gonococcal surveillance programme annual report, 2020. MM Lahra, TR Hogan, M Shoushtari, BH Armstrong | 191* | 2021 |
| Changing epidemiology of candidaemia in Australia B Chapman, M Slavin, D Marriott, C Halliday, S Kidd, I Arthur, N Bak, ... Journal of Antimicrobial Chemotherapy 72 (4), 1103-1108, 2017 | 181 | 2017 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial E Abaleke, M Abbas, S Abbasi, A Abbott, A Abdelaziz, S Abdelbadiee, ... The Lancet 397 (10274), 605-612, 2021 | 124 | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10325), 665-676, 2022 | 79 | 2022 |
| Antimicrobial resistance trends in bacterial keratitis over 5 years in Sydney, Australia M Cabrera‐Aguas, P Khoo, CRR George, MM Lahra, SL Watson Clinical & Experimental Ophthalmology 48 (2), 183-191, 2020 | 64 | 2020 |
| Screening, assessment and management of type 2 diabetes mellitus in children and adolescents: Australasian Paediatric Endocrine Group guidelines AS Peña, JA Curran, M Fuery, C George, CA Jefferies, K Lobley, ... Medical Journal of Australia 213 (1), 30-43, 2020 | 55 | 2020 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10320), 143-151, 2022 | 52 | 2022 |
| Systematic review and survey of Neisseria gonorrhoeae ceftriaxone and azithromycin susceptibility data in the Asia Pacific, 2011 to 2016 CRR George, RP Enriquez, BJ Gatus, DM Whiley, YR Lo, N Ishikawa, ... PLoS One 14 (4), e0213312, 2019 | 37 | 2019 |
| Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study C Fotopoulou, T Khan, J Bracinik, J Glasbey, N Abu-Rustum, L Chiva, ... American Journal of Obstetrics & Gynecology 227 (5), 735. e1-735. e25, 2022 | 36 | 2022 |
| Australian and New Zealand Mycoses Interest Group. Changing epidemiology of candidaemia in Australia B Chapman, M Slavin, D Marriott, C Halliday, S Kidd, I Arthur, N Bak, ... J Antimicrob Chemother 72 (4), 1103-1108, 2017 | 34 | 2017 |
| Epidemiology of late and very late onset group B streptococcal disease: fifteen-year experience from two Australian tertiary pediatric facilities AW Bartlett, B Smith, CRR George, B McMullan, A Kesson, MM Lahra, ... The Pediatric infectious disease journal 36 (1), 20-24, 2017 | 33 | 2017 |
| Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open … O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 401 (10387), 1499-1507, 2023 | 24 | 2023 |
| Azithromycin-resistant Neisseria gonorrhoeae spreading amongst men who have sex with men (MSM) and heterosexuals in New South Wales, Australia, 2017 DM Whiley, RL Kundu, AV Jennison, C Buckley, A Limnios, T Hogan, ... Journal of Antimicrobial Chemotherapy 73 (5), 1242-1246, 2018 | 23 | 2018 |
| Topical cidofovir for treatment-refractory ocular surface squamous neoplasia MH Ip, CRR George, Z Naing, EM Perlman, W Rawlinson, MT Coroneo Ophthalmology 125 (4), 617-619, 2018 | 22 | 2018 |
| Bacterial Ocular Surveillance System (BOSS) Sydney, Australia 2017-2018. SL Watson, BJ Gatus, M Cabrera-Aguas, BH Armstrong, R George, ... | 20 | 2020 |
| Australian Gonococcal Surveillance Programme, 1 July to 30 September 2016. MM Lahra, RP Enriquez | 18* | 2017 |
| Prolonged second diagnostic window for human immunodeficiency virus type 1 in a fourth-generation immunoassay: are alternative testing strategies required? CRR George, PW Robertson, MJ Lusk, R Whybin, W Rawlinson Journal of clinical microbiology 52 (11), 4105-4108, 2014 | 17 | 2014 |
